Skip to main content
Markdown filings API. Get API access →
OICS v0.3.3 class · Healthcare

Clinical-Stage Biotech

ID CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company Ticker Country Market cap Filings
Cannabotech Ltd. CNTC Israel $107k 1,025
Pluri Inc. PLUR United States of America — 2,932
Lakefront Biotherapeutics NV GLPG Belgium — 2,877
Suven Life Sciences Ltd. SUVEN India — 2,346
OBI Pharma, Inc. 4174 Taiwan — 2,127
IMMUTEP LIMITED IMM Australia — 1,891
Cereno Scientific AB CRNO Sweden — 1,874
Sun Pharma Advanced Research Company Ltd. SPARC India — 1,874
SYNTARA LIMITED SNT Australia — 1,715
Chabiotech Co.,Ltd. 085660 South Korea — 1,655
AROVELLA THERAPEUTICS LIMITED ALA Australia — 1,618
NATURECELL CO.,LTD. 007390 South Korea — 1,581
IMUGENE LIMITED IMU Australia — 1,498
NEURIZON THERAPEUTICS LIMITED NUZ Australia — 1,462
HYUNDAI BIOSCIENCE CO., LTD. 048410 South Korea — 1,443
DIMERIX LIMITED DXB Australia — 1,381
PYC THERAPEUTICS LIMITED PYC Australia — 1,372
CG Invites Co., Ltd. 083790 South Korea — 1,370
STARPHARMA HOLDINGS LIMITED SPL Australia — 1,360
ARGENT BIOPHARMA LIMITED RGT Australia — 1,353
Senhwa Biosciences, Inc. 6492 Taiwan — 1,343
Helixmith Co., Ltd 084990 South Korea — 1,282
PERCHERON THERAPEUTICS LIMITED PER Australia — 1,243
CYNATA THERAPEUTICS LIMITED CYP Australia — 1,197
STCUBE 052020 South Korea — 1,196
INVION LIMITED IVX Australia — 1,189
ALGORAE PHARMACEUTICALS LIMITED 1AI Australia — 1,183
ACTINOGEN MEDICAL LIMITED ACW Australia — 1,132
Eloxx Pharmaceuticals, Inc. ELOX United States of America — 1,121
NKMAX Co., Ltd. 182400 South Korea — 1,082
Hyper Corporation Inc. 065650 South Korea — 1,076
Dicot Pharma AB DICOTBT Sweden — 1,044
PRESCIENT THERAPEUTICS LIMITED PTX Australia — 1,035
AUREKA LIMITED AKA Australia — 1,015
RACURA ONCOLOGY LTD RAC Australia — 990
PALATIN TECHNOLOGIES INC PTN United States of America — 972
Genexine, Inc. 095700 South Korea — 960
Diamyd Medical AB (publ) DMYD Sweden — 949
OSCOTECInc. 039200 South Korea — 948
PATRYS LIMITED PAB Australia — 941
ERYTECH Pharma S.A. ERYP France — 934
AVECHO BIOTECHNOLOGY LIMITED AVE Australia — 900
Ascletis Pharma Inc. 1672 Cayman Islands — 876
Mydecine Innovations Group Inc. MYCO Canada — 868
Ever Supreme Bio Technology Co., Ltd 6712 Taiwan — 839
HEALIOS K.K. 4593 Japan — 806
NOXOPHARM LIMITED NOX Australia — 802
MEDICINOVA INC MNOV United States of America — 785
BIOTRON LIMITED BIT Australia — 781
iNtRON Biotechnology, Inc. 048530 South Korea — 774

Companies in Biotechnology → Open in the screener →

Other names for this activity, and where neighboring activities go instead.

Also known as

preclinicaldrug developer

Not here
Commercial Biotech CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.

https://financialfilings.com/oics/CLB/

This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard